112 related articles for article (PubMed ID: 2455388)
1. Features of T-cell recognition and antigen structure useful in the design of vaccines to elicit T-cell immunity.
Berzofsky JA
Vaccine; 1988 Apr; 6(2):89-93. PubMed ID: 2455388
[TBL] [Abstract][Full Text] [Related]
2. Protein antigenic structures recognized by T cells: potential applications to vaccine design.
Berzofsky JA; Cease KB; Cornette JL; Spouge JL; Margalit H; Berkower IJ; Good MF; Miller LH; DeLisi C
Immunol Rev; 1987 Aug; 98():9-52. PubMed ID: 2443443
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of T cell recognition with application to vaccine design.
Berzofsky JA
Mol Immunol; 1991 Mar; 28(3):217-23. PubMed ID: 1708102
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of immunodominance in T-cell recognition, with applications to vaccine design.
Berzofsky JA
Princess Takamatsu Symp; 1988; 19():161-77. PubMed ID: 2479631
[TBL] [Abstract][Full Text] [Related]
5. Structural features of T-cell recognition: applications to vaccine design.
Berzofsky JA
Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):535-44. PubMed ID: 2474171
[TBL] [Abstract][Full Text] [Related]
6. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
Cease KB; Margalit H; Cornette JL; Putney SD; Robey WG; Ouyang C; Streicher HZ; Fischinger PJ; Gallo RC; DeLisi C
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4249-53. PubMed ID: 2438696
[TBL] [Abstract][Full Text] [Related]
7. Identification of T-cell epitopes and use in construction of synthetic vaccines.
Cornette JL; Margalit H; DeLisi C; Berzofsky JA
Methods Enzymol; 1989; 178():611-34. PubMed ID: 2481216
[TBL] [Abstract][Full Text] [Related]
8. Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.
Good MF; Maloy WL; Lunde MN; Margalit H; Cornette JL; Smith GL; Moss B; Miller LH; Berzofsky JA
Science; 1987 Feb; 235(4792):1059-62. PubMed ID: 2434994
[TBL] [Abstract][Full Text] [Related]
9. Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA.
Rzepczyk CM; Ramasamy R; Ho PC; Mutch DA; Anderson KL; Duggleby RG; Doran TJ; Murray BJ; Irving DO; Woodrow GC; Parkinson D; Brabin BJ; Alpers MP
J Immunol; 1988 Nov; 141(9):3197-202. PubMed ID: 2459246
[TBL] [Abstract][Full Text] [Related]
10. Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: implications for T cell antigenic structure.
Berkower I; Buckenmeyer GK; Berzofsky JA
J Immunol; 1986 Apr; 136(7):2498-503. PubMed ID: 2419437
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.
Togna AR; Del Giudice G; Verdini AS; Bonelli F; Pessi A; Engers HD; Corradin G
J Immunol; 1986 Nov; 137(9):2956-60. PubMed ID: 2428881
[TBL] [Abstract][Full Text] [Related]
12. T-cell antigenic peptides from sperm whale myoglobin fold as amphipathic helices: a possible determinant for immunodominance?
Lark LR; Berzofsky JA; Gierasch LM
Pept Res; 1989; 2(5):314-21. PubMed ID: 2520770
[TBL] [Abstract][Full Text] [Related]
13. Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicity.
Jolivet M; Lise L; Gras-Masse H; Tartar A; Audibert F; Chedid L
Vaccine; 1990 Feb; 8(1):35-40. PubMed ID: 1690488
[TBL] [Abstract][Full Text] [Related]
14. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
[TBL] [Abstract][Full Text] [Related]
15. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
16. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.
Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577
[TBL] [Abstract][Full Text] [Related]
17. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
Good MF; Branigan J; Smith G; Houghten RA
Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
[TBL] [Abstract][Full Text] [Related]
18. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
[TBL] [Abstract][Full Text] [Related]
19. Immune response of humans to the circumsporozoite protein of Plasmodium falciparum: limited T cell response to the immunodominant central repeat region.
Campbell JR; Paleologo FP; Franke ED; Ratiwayanto S; Hadiputranto H; Kurniawan L; Wistar R; Hoffman SL; Annis BA; Wasserman G
Am J Trop Med Hyg; 1988 Sep; 39(3):232-5. PubMed ID: 2459979
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
